Thrivent Financial for Lutherans Has $124.66 Million Stock Position in Encompass Health Corporation $EHC

Thrivent Financial for Lutherans reduced its position in shares of Encompass Health Corporation (NYSE:EHC) by 1.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,176,582 shares of the company’s stock after selling 18,277 shares during the period. Thrivent Financial for Lutherans’ holdings in Encompass Health were worth $124,659,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Jennison Associates LLC raised its stake in shares of Encompass Health by 12.8% in the third quarter. Jennison Associates LLC now owns 894,511 shares of the company’s stock worth $113,621,000 after purchasing an additional 101,274 shares during the last quarter. Tudor Investment Corp ET AL raised its stake in shares of Encompass Health by 155.3% in the third quarter. Tudor Investment Corp ET AL now owns 210,712 shares of the company’s stock worth $26,765,000 after purchasing an additional 128,191 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of Encompass Health by 5.3% in the third quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock worth $179,141,000 after purchasing an additional 70,387 shares during the last quarter. AlphaQuest LLC raised its stake in shares of Encompass Health by 170.9% in the third quarter. AlphaQuest LLC now owns 29,916 shares of the company’s stock worth $3,800,000 after purchasing an additional 18,874 shares during the last quarter. Finally, SG Americas Securities LLC raised its stake in shares of Encompass Health by 1,070.9% in the fourth quarter. SG Americas Securities LLC now owns 88,054 shares of the company’s stock worth $9,346,000 after purchasing an additional 80,534 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the business’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares in the company, valued at approximately $9,557,775. This represents a 11.79% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.80% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Barclays lowered their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $144.17.

Encompass Health Stock Down 0.1%

EHC stock opened at $107.36 on Friday. The stock’s fifty day simple moving average is $102.99 and its two-hundred day simple moving average is $106.40. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99. The stock has a market cap of $10.65 billion, a P/E ratio of 17.92, a P/E/G ratio of 2.34 and a beta of 0.72.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. The business’s revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Analysts expect that Encompass Health Corporation will post 5.97 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s payout ratio is currently 12.69%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.